The global interventional cardiology devices market size reached a value of US$ 19.58 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 32.21 Billion by 2027, exhibiting a CAGR of 8.40% during 2022-2027.
Interventional cardiology devices are small, flexible medical equipment used to repair damaged or weakened vessels, narrowed arteries, or other affected parts of the heart’s structure. They are also utilized to measure blood flow in the major arteries and treat genetic and structural heart conditions through catheter-based procedures, such as angioplasty and stenting. Some commonly used interventional cardiology devices are coronary stents, catheters, intravascular ultrasound (IVUS) catheters, hemodynamic flow alteration, guidewire, angioplasty balloons, tricuspid valves, and introducer sheath.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/interventional-cardiology-devices-market/requestsample
Interventional Cardiology Devices Market Trends and Drivers:
The market is primarily driven by the growing prevalence of coronary artery disease (CAD), diabetes, and hypertension, especially among the geriatric population. Besides this, the introduction of ingenious bioabsorbable and drug-eluting stents, pacemakers, and drug-coated mesh tubes is also creating a favorable market outlook.
Moreover, the market is further propelled by the rising adoption of advanced imaging solutions, such as intravenous ultrasound (IVUS) and fractional flow reserve (FFR) for diagnostic purposes.
In addition, other factors such as significant developments in healthcare facilities, increasing demand for minimally invasive treatment, and growing awareness regarding early diagnosis and timely treatment of cardiovascular ailments are also augmenting the market growth.
Global Interventional Cardiology Devices Market 2022-2027 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Abbott Laboratories, Alvimedica, B. Braun Melsungen AG, Biosensors International Group Ltd. (Bluesail Medical Co. Ltd.), BIOTRONIK Inc., Boston Scientific Corporation, Cook Group Incorporated, ENDOCOR GmbH, Koninklijke Philips N.V., Medinol Ltd., Medtronic plc and Terumo Corporation.
Inquire Before Buying : https://www.imarcgroup.com/request?type=report&id=5629&flag=F
The report has segmented the market on the basis of region, product and end user.
Breakup by Product:
Drug Eluting Stents
Bare Metal Stents
Balloon Inflation Device
Drug Eluting Balloons
Breakup by End User:
Ambulatory Surgical Centers
Breakup by Region:
North America: (United States, Canada)
Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
Latin America: (Brazil, Mexico, Others)
Middle East and Africa
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
Market Performance (2016-2021)
Market Outlook (2022- 2027)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800